Health Canada announces $11.78 million in funding to help support people who use substances in British Columbia 

To help support the response to the overdose crisis and address harms related to substance use and the toxic illegal drug supply, over the last two years, the Government of Canada has dedicated over $182 million to Health Canada’s Substance Use and Addictions Program (SUAP), and recently proposed another $100 million through Budget 2022. $11.78 million in funding has been granted to 14 innovative community-led projects in British Columbia.  

With this funding, these projects will help to improve health outcomes for people who are at risk of experiencing substance-related harms and overdose by scaling up prevention, harm reduction and treatment efforts across British Columbia.

Funding is provided through the Substance Use and Addictions Program (SUAP), which supports evidence-informed and innovative initiatives across a range of interventions—health promotion, prevention, harm reduction and treatment—targeting a broad range of legal and illegal substances.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below